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ABSTRACT
The RNA-binding protein nuclear factor 90 (NF90)
has been implicated in the stabilization, transport
and translational control of several target mRNAs.
However, a systematic analysis of NF90 target
mRNAs has not been performed. Here, we use
ribonucleoprotein immunoprecipitation analysis to
identify a large subset of NF90-associated mRNAs.
Comparison of the 30-untranslated regions (UTRs) of
these mRNAs led to the elucidation of a 25- to
30-nucleotide, RNA signature motif rich in
adenines and uracils. Insertion of the AU-rich NF90
motif (‘NF90m’) in the 30UTR of an EGFP
heterologous reporter did not affect the steady-
state level of the chimeric EGFP-NF90m mRNA or
its cytosolic abundance. Instead, the translation of
EGFP-NF90m mRNA was specifically repressed in
an NF90-dependent manner, as determined by
analysing nascent EGFP translation, the distribution
of chimeric mRNAs on polysome gradients and the
steady-state levels of expressed EGFP protein. The
interaction of endogenous NF90 with target mRNAs
was validated after testing both endogenous
mRNAs and recombinant biotinylated transcripts
containing NF90 motif hits. Further analysis
showed that the stability of endogenous NF90
target mRNAs was not significantly influenced by
NF90 abundance, while their translation increased
when NF90 levels were reduced. In summary, we
have identified an AU-rich RNA motif present in
NF90 target mRNAs and have obtained evidence
that NF90 represses the translation of this subset
of mRNAs.
INTRODUCTION
In mammalian cells, gene expression is potently regulated
at the post-transcriptional level. RNA-binding factors,
including noncoding RNA and RNA-binding proteins
(RBPs), inﬂuence many post-transcriptional processes,
including pre-mRNA splicing and mRNA transport,
degradation, storage and translation (1,2). Some RBPs
aﬀect one speciﬁc post-transcriptional process; for
example, tristetraprolin (TTP) and KH-type splicing
regulatory protein (KSRP) promote mRNA degradation
(3–5). However, most RBPs perform multiple post-
transcriptional functions. For example, HuR (human
antigen R) stabilizes some target mRNAs but modulates
the translation of other target mRNAs (6), AUF1 (AU-
binding factor 1) promotes the decay of some mRNAs but
can also stabilize and promote the translation of other
target transcripts (7–11), the T-cell intracellular antigen-
1 (TIA-1) and the TIA-1-related protein (TIAR) are
implicated in splicing and translational repression of
target transcripts (12–14) and the polypyrimidine tract-
binding protein can modulate splicing, stability and
translation of target mRNAs (15,16). In general, these
RBPs associate with sequences within the 30-untranslated
region (UTR) of the target transcript, but sometimes
with the 50UTR or with the coding region (17,18,
reviewed in 19).
One multi-functional RBP is the nuclear factor (NF)90,
also named NFAR (nuclear factor associated dsRNA)-1,
double-stranded (ds) RNA-binding protein (DRBP76)
and interleukin (IL) enhancer-binding factor 3 (ILF3).
NF90 was ﬁrst identiﬁed as a 90-kDa protein that
interacted with the NFAT (nuclear factor activated in
T-cells) DNA site present in the IL-2 promoter (20,21).
With two dsRNA-binding domains (DRBDs), NF90 was
later shown to interact with the  -glucosidase mRNA
(22,23) and viral RNA (24); it was also shown to bind
*To whom correspondence should be addressed. Tel: +1 410 558 8443; Fax: +1 410 558 8386; Email: myriam-gorospe@nih.gov
The authors wish it to be known that, in their opinion, the ﬁrst two authors should be regarded as joint First Authors.
Published online 22 October 2009 Nucleic Acids Research, 2010, Vol. 38, No. 1 225–238
doi:10.1093/nar/gkp861
Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.the protein kinase activated by dsRNA (PKR) (25,26).
Through alternative splicing, the gene that encodes
NF90 also gives rise to NF110; both proteins are
ubiquitously expressed and are primarily present in the
nucleus, although they can be transported to the cyto-
plasm under speciﬁc conditions, such as during the cell
division cycle and in response to damaging agents
(27,28). Although NF110 has been investigated in some
depth (29), NF90 has been studied in greater detail.
As mentioned earlier, NF90 can bind to the NFAT
DNA sequence, and thereby modulates the transcription
of IL-2 (20,30,31). However, NF90 potently regulates
gene expression through its association with RNA.
NF90 was shown to bind the several mRNAs containing
AU-rich 30UTRs; this interaction led to the stabilization
of the IL-2 mRNA during T-cell activation, the mitogen-
activated protein kinase phosphatase 1 (MKP-1) mRNA
in response to oxidative damage, and the vascular
endothelial growth factor mRNA in response to hypoxic
stress (28,32,33). NF90 also stabilized the mRNAs
encoding the cyclin-dependent kinase inhibitor p21
Cip1
and the myogenic transcription factor MyoD (34);
additionally, NF90 bound the NF90 mRNA and
possibly aﬀected its expression (35). In vitro, NF90
associated with the  -glucosidase mRNA and inhibited
its translation (22,23). Pfeifer and colleagues (2008)
recently showed that NF90 can also function as a
general inhibitor of mRNA export to the cytoplasm;
while this eﬀect alone could block translation broadly,
the authors proposed that NF90 could further prevent
translation through its association with polysomes (36).
Our previous studies showing that NF90 selectively
associated with the MKP-1 mRNA, together with the
speciﬁc interaction of NF90 with other mRNAs (28,35),
led us to postulate that NF90 may interact preferentially
with speciﬁc RNA sequences. To test this possibility, we
studied the collection of mRNAs that interacted with
NF90 by performing ribonucleoprotein immunopre-
cipitation (RNP IP) analysis followed by microarray
identiﬁcation of bound mRNAs. Comparison of the
interacting mRNAs led to the identiﬁcation of a 25- to
30-nt-long, highly AU-rich motif sequence shared by
NF90-associated mRNAs. The addition of the consensus
motif to a heterologous GFP reporter revealed that NF90
selectively repressed the translation of a chimeric mRNA
bearing this sequence but did not appear to inﬂuence the
stability of the chimeric mRNA. NF90 was also found to
repress the translation of endogenous mRNAs bearing
the AU-rich signature sequence, without aﬀecting their
half-lives.
MATERIALS AND METHODS
Cell culture and transfection
HeLa cells were maintained in Dulbecco’s modiﬁed
essential medium (Invitrogen), supplemented with 10%
(v/v) bovine calf serum (Hyclone, Logan, UT, USA).
For silencing NF90 expression, Oligofectamine
(Invitrogen) was used to transfect cells with siRNAs.
The NF90 siRNA was GCCCACCUUUGCUUU
UUAU; it targetted NF90 at exon 18 and therefore
selectively reduced NF90 and did not aﬀect NF110
levels. AllStars negative control siRNA was from Qiagen.
Illumina oligonucleotide microarray analysis
The quality and quantity of RNA in the material obtained
after IP reactions using either anti-NF90 or IgG
antibodies were assessed using an Agilent 2100
bioanalyzer and the RNA 6000 nanochips. The RNA
was used to generate biotin-labeled cRNA using the
Illumina TotalPrep RNA Ampliﬁcation Kit (Ambion;
Austin, TX, USA cat # IL1791), which was then
hybridized to Illumina’s Sentrix HumanRef-8 Expression
BeadChips (Illumina, San Diego, CA, USA), containing
24000 well-annotated RefSeq transcripts with  30-fold
redundancy. The arrays were scanned using an Illumina
BeadStation 500X Genetic Analysis Systems scanner and
the image data extracted using Illumina BeadStudio
software, version 1.5. The data were normalized by
Z-score transformation and used to calculate diﬀerences
in signal intensities. Signiﬁcant values were calculated
from three independent experiments, using a two-tailed
Z-test and P<0.01. The complete list of NF90-enriched
mRNAs identiﬁed on arrays is shown in Supplementary
Table S1.
Computational analysis
The top  800 human transcripts enriched in NF90 IP
served as the experimental dataset (Supplementary Table
S1) for the computational identiﬁcation of the NF90
motif. The transcript sequences (UniGene) were scanned
with RepeatMasker (www.repeatmasker.org) to remove
repetitive sequences, and complete, high-quality 30UTR
sequences were selected for further analysis. The selected
sequences were ﬁrst divided into 100-base-long
subsequences with a 50-base overlap between consecutive
sequences and were organized into 50 datasets. Common
RNA motifs were then elucidated from each of the 50
random datasets. The top 10 candidate motifs from each
random dataset were selected and used to build the
stochastic context-free grammar (SCFG) model, which
summarizes the folding, pairing and additional secondary
structure features. The SCFG model of each candidate
motif was then used to search against the experimental
30UTR dataset as well as the entire human UniGene
30UTR dataset to obtain the number of hits for each
motif. The motif with the highest enrichment in the
experimental dataset compared with the entire UniGene
dataset was considered to be the top NF90 candidate
motif. The enrichment was examined by Fisher’s exact
test. The identiﬁed RNA motif for NF90 forms a stem-
loop.
The identiﬁcation of the RNA motif in unaligned
sequences was conducted using FOLDALIGN software
(37), and the identiﬁed motif was modeled by the SCFG
algorithm and searched against the transcript dataset
using the COVE and COVELS software packages (38).
The motif logo was constructed using WebLogo
(http://weblogo.berkeley.edu/). RNAplot was used to
depict the secondary structure of the representative
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NIH Biowulf computer farm. Both UniGene and RefSeq
datasets were downloaded from NCBI.
Cell fractionation, RNA puriﬁcation and western blot
analysis
Cells were incubated on ice for 5minina cytoplasmic lysis
(RSB) buﬀer containing 10mM Tris–HCl (pH 7.4),
100mM NaCl, 2.5mM MgCl2,4 0 mg/ml digitonin,
1000U/ml of RNaseOUT and protease inhibitors, and
then centrifuged (2000 g) for 8min. After removing the
supernatant (cytoplasmic fraction), the pellet was
resuspended in the 200 ml RSB buﬀer+40mg/ml digitonin
(containing 1000U/ml RNaseOUT and protease inhib-
itors), kept on ice for 5min, and centrifuged (2000 g)
for 8min; this step was repeated twice, and then the
supernatant (the cytosolic fraction) was removed. The
pellet was incubated on ice for 10minin the presence of
100 ml of the RIPA buﬀer and was centrifuged (20800 g).
The supernatant (nuclear fraction) was collected for
analysis.
For western blot analysis, whole-cell lysates (10mg)
were resolved by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred onto
polyvinylidene diﬂuoride (PVDF) membranes. Primary
antibody incubations were performed using antibodies
that recognized NF90 (mouse monoclonal anti-DRBP76,
BD Transduction Laboratories), GAPDH, EGFP,
a-tubulin, HuR, cyclin A, cdc2 (mouse monoclonal,
Santa Cruz Biotech.), cyclin I (rabbit polyclonal,
SantaCruz Biotech.), eIF4E (rabbit polyclonal, Cell
Signaling) and b-actin (mouse monoclonal, Abcam).
Following incubation with the appropriate secondary
antibodies, the signals were detected with the ECL
TM
reagent (Amersham Biosciences).
Binding assays: IP and biotin pulldown
IP of endogenous NF90-mRNA complexes was carried
out using previously described methods (39–41). Brieﬂy,
20 million HeLa cells per sample were lysed and used
for IP [1h at 4 C in the presence of 30mg of either
an anti-NF90 antibody (mouse monoclonal, BD Trans-
duction Laboratories) or control mouse IgG (Santa Cruz
Biotech.]. RNA was isolated using acid phenol-
chloroform (Ambion).
For biotin pulldown assays, PCR fragments con-
taining the T7 RNA polymerase promoter sequence
(T7): CCAAGCTTCTAATACGACTCACTATAGGGA
GA were used as a templates for in vitro transcription of
the 30UTRs of eIF4E, DCK, C1D, CDC2, CCN1, ETF1,
PCNA, PMSA, XBP-1 and UBC using biotinylated CTP.
Two mg of biotinylated transcript was incubated with
80mg of lysate (cytoplasmic or nuclear) for 30min at
room temperature, following which the complexes were
isolated with streptavidin-coated magnetic Dynabeads
(Dynal) and the pulldown material was analyzed by
standard western blotting.
Oligonucleotides used to prepare templates
for in vitro biotinylated transcription and
pulldown assay
The following primer pairs (forward and reverse,
respectively) were used:
(T7) GAAGACACCTTCTGAGTATTCTCA and CAG
TTTTGTACACTGTCTTAATATGAA for eIF4E,
(T7) TCTTGCTGAAGACTACAGGCAG and GAGT
CATGACAAATAAATAATAAATTTTTATT for
DCK,
(T7) GGTCAGTCTTGCAAGTACCATTT and GGGA
CATAGAGGCAACATGC for C1D,
(T7) CTTTCTGACAAAAAGTTTCCATATG and TCC
CAAAGCTAGTAATTTTAGTTAAAT for CDC2,
(T7) AGTGGGTGCAAGCAGACCT and TTCTGGCT
CACTCCAAATCA for CCN1,
(T7) CTATTGCTGGGATTGGGAGA and AGGGTTT
CAGGCCAACTTTT for ETF1,
(T7) CCCAAGATCGAGGATGAAGA and TGCATTT
AGAGTCAAGACCCTTT for PCNA,
(T7) GGCTGATGAACCAATGGAAC and CAGGCG
GTGAAACAATTTTA for PMSA1,
(T7) TCAGCCCCTCAGAGAATGAT and TCTGCTA
TCCTCCAGGCAGT for XBP-1 and
(T7) GGTGCTCCGTCTCAGAGGT and TTGAAAGG
AAAGTGCAATGAAA for UBC.
RT followed by real-time, quantitative PCR
Total RNA or RNA isolated from the IPs was reverse
transcribed (RT) using random hexamers and subjected
to quantitative PCR (qPCR) to assess the abundance of
the products using the gene-speciﬁc primer pairs listed
below. Analysis was performed using the QuantiTect
SYBR Green PCR kit (Qiagen) and an ABI Prism 7000
detection system with the ABI Prism 7000 SDS software.
To measure the relative mRNA stabilities in cells with
normal NF90 or reduced NF90 levels, cultures were
treated with actinomycin D (2mg/ml) for the times
shown. At subsequent times, mRNA levels were
measured by RT-qPCR, normalized to 18S rRNA levels,
and plotted on a semi-logarithmic scale to calculate the
time required for each mRNA to reach one-half of its
initial abundance (50%, dashed line).
Oligonucleotides for RT-qPCR-mediated
detection of mRNAs in IP materials and
in total RNA
Oligonucleotide pairs (forward and reverse, respectively)
to detect mature mRNAs were as follows:
CACATGAAGCAGCACGACTT and GGATGTTGCC
GTCCTCCTTG for EGFP,
CAGATGGGCACTCTGGTTTT and CTCCCCGTTT
GTTTTTCTCA for eIF4E,
AGCAAGGCATTCCTCTTGAA and AACCATTTGG
CTGCCTGTAG for DCK,
GCTGTGGATGAGATGCTGAA and TGCCAGCCTT
TTTCTTGTCT for C1D,
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GAAATTCGT for CDC2,
GGCGTGAACCTCACCAGTAT and TCTCGGCATA
TACGTGCAAA for PCNA,
GCGTCAGGAGTGTTTGGATT and GACATGGCTC
TGCAGTCAAAfor PMSA1,
GCCAAATTGCCCTATCTCAA and CAGAAAAATG
GGCAAAGGAA for EIF2A,
AAGAAGCCAGCTGAATCTCAAA and GGTCCAG
GTAAACTAATGGCTGAA for CYCA,
TAGCTGGATCCGCTGACTTT and AACAGTACTT
GCCCGTGTCC for ETF1,
ACATCAAGAAGGTGGTGAAGCAGG and CCAGC
AAGGATACTGAGAGCAAGAG for GAPDH,
GCATCCTGCAGCAGATACAA and CAGCTTCACC
GACTTCATCA for MYBBP1a,
CCACCTGCCTTCTCACTAGC and TGGGAAATCT
CAAGGACTGG for P2RY2,
CAAGAAGCAGGTCTCGATCC and CCACGTTTCT
GGCTCTTCTC for SFRS5,
GGAATGGAGCAGTTGGAAAA and TGACCTGCA
GTGTCCCATAA for RAB23,
GTCGATCCAAAAGTGGCAAT and TTCCATGGCA
GCTTCTTTCT for TCERG1,
TACATCGACACCACCTGGAA and GCCAGGTTCC
TCATCAAAAA for SURF4 and
ATTTGGGTCGCGGTTCTTG and TGCCTTGACAT
TCTCGATGGT for UBC.
Analysis of translation: polysome gradients and nascent
translation assay
For polysome analysis, 48h after transfection of control
siRNA or NF90 siRNA, HeLa cells were incubated with
0.1mg/ml cycloheximide for 10min. Cytoplasmic extracts
(1mg each) were prepared and fractionated through a
linear sucrose gradient [10–50% (w/v)], as previously
reported (28). Ten fractions were collected using a
fraction collector (Brandel) and monitored by optical
density measurement (A254). The RNA in each fraction
was isolated with Trizol LS (Invitrogen). Following RT,
qPCR analysis was performed using primer pairs for
EGFP, UBC, CYCA and EIF4E.
The levels of nascent (de novo translated) EGFP,
GAPDH, Cdc2 and Cyclin A were measured by
incubating HeLa cells brieﬂy (20min) with 1mCi L-
[
35S]methionine and L-[
35S]cysteine (Easy Tag
TMEXPRESS, NEN/Perkin Elmer, Boston, MA, USA)
per 60mm plate, as shown earlier (28). Cells were lysed
in RIPA buﬀer [10mM Tris-HCl (pH 7.4), 150mM NaCl,
1% NP-40, 1mM EDTA, 0.1% SDS and 1mM DTT] and
the IP reactions were carried out in 1ml TNN buﬀer
[50mM Tris-HCl (pH 7.5), 250mM NaCl, 5mM EDTA,
0.5% NP-40] for 16h at 4 C using antibodies that
recognized EGFP, GAPDH, Cdc2 or Cyclin A (Santa
Cruz Biotech.) or using IgG1. Following extensive
washes in the TNN buﬀer, the IP samples were resolved
by SDS-PAGE, transferred onto PVDF ﬁlters, and
visualized and quantiﬁed using a PhosphorImager
(Molecular Dynamics).
RESULTS
High-throughput identiﬁcation of NF90 target mRNAs
In order to identify the collection of mRNAs associated
with NF90, we performed RNP IP analysis using an anti-
NF90 antibody, under conditions that preserved the
association of NF90 ribonucleoprotein complexes, as
previously described (28,35). The RNA in the NF90 IP
samples and in the control IgG IP samples (Figure 1A)
was isolated and used for reverse transcription and
hybridization of Illumina microarrays (‘Materials and
Methods‘ section; Figure 1B). A partial list of transcripts
that were speciﬁcally enriched in NF90 IP relative to IgG
IP is shown (Figure 1C); see Supplementary Table S1 for a
complete list of mRNAs enriched in NF90 IP samples.
The top  800 transcripts speciﬁcally isolated in
association with NF90 (the experimental dataset) were
used for computational analysis to identify the conserved
RNA signature motif, based on both primary sequences
and secondary structures (‘Materials and Methods’
section). Among the 100 possible candidate motifs
identiﬁed from the experimental dataset, one motif
comprising 25–30 nucleotides showed the highest
frequency of hits per kb in the experimental dataset over
the entire UniGene transcript sequence database. The logo
of this motif, which is a graphic representation of the
relative frequency of nucleotides at each position,
revealed a bi-partitite sequence, highly A-rich in one half
and U-rich in the other half (Figure 1A); together,
nucleotides A and U comprised 92% of the signature
motif sequence. Depicted in Figure 2B and C are six
speciﬁc hits of the AU-rich NF90 sequence on speciﬁc
mRNAs and their predicted folding patterns into hairpin
loop structures.
The NF90 signature motif confers translational repression
to target mRNAs
To assess the inﬂuence of this signature motif upon the
mRNA sequence in which it is found, we studied the
consequences of adding the motif to a heterologous
reporter. A control plasmid expressing EGFP with a
400bp segment of the housekeeping GAPDH 30UTR
(pEGFP-GAPDH) was used as the backbone reporter. It
was used to generate a reporter construct that contained
the ‘ideal’ (most frequent nucleotides at each position)
AU-rich NF90 motif, pEGFP-NF90m, as well as another
reporter construct that contained one speciﬁc motif hit on
the DCK mRNA, pEGFP-DCKm (Figure 3A). Following
transfection of the plasmids into HeLa cells, NF90 RNP
IP analysis showed that both EGFP-NF90m and EGFP-
DCKm mRNAs were enriched in NF90 IP samples
relative to IgG samples by  6-fold greater than the
control, EGFP-GAPDH mRNA (Figure 3B), indicating
that the two chimeric reporter mRNAs containing the
NF90 motif had become NF90 targets.
Next, an intervention to silence NF90 by transfection
with small interfering (si)RNA was used to study the
inﬂuence of NF90 on the expression of the two NF90
reporter target transcripts. As shown in Figure 3B,
NF90 was silenced eﬀectively, reaching a >90% reduction
228 Nucleic Acids Research, 2010,Vol. 38,No. 1in abundance, when compared to the intensity seen in the
control (Ctrl siRNA) transfection group. The presence of
NF90m or DCKm lowered slightly the basal EGFP levels
(compare the three Ctrl siRNA samples), but NF90
silencing increased EGFP expression in each case: by
 3.4-fold for the EGFPm reporter and 2.9-fold for the
DCKm reporter. This increase did not appear to be due
to selective mRNA stabilization when NF90 was silenced,
Figure 1. Identiﬁcation of NF90 target mRNAs en masse by RNP IP and microarray analysis. (A) Following IP from untreated HeLa cells using
either anti-NF90 or IgG antibodies, NF90 was detected by western blot analysis. (B) Schematic of the experimental approach. HeLa cell lysates were
subjected to IP with either IgG or anti-NF90 antibodies. The collections of RNAs isolated from each IP reaction were identiﬁed using microarrays.
(C) Partial table of mRNAs enriched in the NF90 IP samples relative to the control IgG IP samples; relative enrichment is indicated in the form of Z
ratios (details in the ’Materials and Methods‘ section).
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DCKm mRNA, not shown) were not signiﬁcantly diﬀerent
between the Ctrl siRNA group and the NF90 siRNA
group (Figure 3D). Likewise, the change in translation
did not appear to be due to the NF90-mediated retention
of target transcripts in the nucleus, as suggested by earlier
studies looking globally at polyadenylated mRNAs (36).
As shown in Figure 3E, the relative abundance in the
nucleus and cytosol of the control transcript EGFP-
GAPDH did not change as a function of NF90, nor did
EGFP-NF90m or EGFP-DCKm mRNAs show altered
distribution relative to EGFP-GAPDH, regardless of the
NF90 status. Evidence that the NF90 siRNA (which was
designed to target exon 18, unique to NF90) did not
silence the related protein NF110 (which lacks exon 18)
is shown in Figure 3F. It is important to note that
although the antibody could also recognize NF110, the
relative abundance of NF110 was much lower in these
cells; it is also important to point out that in cells
expressing higher levels of NF110, NF90 siRNA also
speciﬁcally silenced NF90 and did not aﬀect NF110
abundance (not shown).
Instead, we postulated that NF90 might speciﬁcally
lower the translation of these mRNAs. To test this
possibility, we ﬁrst studied the nascent translation of the
EGFP reporter vectors. This assay measured the de novo
synthesis of the reporter protein (EGFP), expressed from
each of the three reporter constructs. Brieﬂy, following
siRNA transfections, cells were incubated for a short
time period (20min) with amino acids
35S-Met and
35S-Cys, whereupon lysates were prepared and the abun-
dance of newly synthesized
35S-EGFP was measured by IP
using anti-EGFP antibodies. As shown in Figure 4A,
nascent EGFP translation in the pEGFP-GADPH
transfection group was not inﬂuenced signiﬁcantly after
silencing NF90; by contrast, in both pEGFP-NF90m
and pEGFP-DCKm transfection groups, nascent EGFP
translation from the encoded transcripts (EGFP-NF90m
and EGFP-DCKm mRNAs) was signiﬁcantly upregulated
in NF90 siRNA-transfected cells. The eﬀect of
NF90 silencing on the increased expression of EGFP
was speciﬁc, as NF90 silencing did not alter the levels
of GAPDH synthesized (
35S-GAPDH), nor did it
signiﬁcantly alter the background amino acid
incorporation (IgG IP).
Further conﬁrmation that NF90 selectively repressed
the translation of EGRP reporter constructs bearing the
NF90 motif was obtained by monitoring the distribution
of EGFP-NF90m mRNA on polysome gradients in Ctrl
and NF90 siRNA populations. As shown in Figure 4B,
there were no major diﬀerences between the global
polysome proﬁles seen in Ctrl siRNA- and NF90
siRNA-transfected cells. The levels of speciﬁc mRNAs
were then measured after isolating RNA from each
gradient fraction: –, fractions in which RNA was not
associated with ribosome components; 40S, 60S, 80S,
small ribosomal subunit, large ribosomal subunit,
monosome, respectively; LMWP, low-molecular-weight
polysomes; HMWP, high molecular weight polysomes.
The RNA in each fraction was then used to perform
reverse transcription (RT) and real-time quantitative (q)
PCR analysis. This assay showed that the relative
distribution of the transcript encoding the housekeeping
protein ubiquitin C (UBC mRNA) was comparable
between Ctrl and NF90 siRNA groups, in cells that had
been transfected with either plasmid pEGFP-GAPDH or
plasmid pEGFP-NF90m (bottom graph). However, the
chimeric EGFP-GAPDH, EGFP-NF90m and EGFP-
DCKm mRNAs showed distinct distribution patterns.
Whereas EGFP-GAPDH mRNA distribution essentially
overlapped between the Ctrl siRNA and the NF90
siRNA groups (top right graph), the EGFP-NF90m
and EGFP-DCKm mRNAs showed a more extensive
association with the actively translating polysome
fraction (HMWP) in the NF90 siRNA group than in the
Ctrl siRNA group (bottom right graph). Together, the
results in Figures 3 and 4 indicate that NF90 speciﬁcally
Figure 2. Sequence and structure of the predicted AUF1 signature
motif identiﬁed among NF90-associated transcripts. (A) Probability
matrix (graphic logo) of an NF90 signature motif, elucidated from
the array-derived experimental dataset, indicating the relative frequency
with which each nucleotide is likely to be found at each position within
the motif. (B) Speciﬁc sequence and secondary structure of six
representative examples of the NF90 motif in speciﬁc mRNAs; the
corresponding gene names are shown.
230 Nucleic Acids Research, 2010, Vol. 38,No. 1Figure 3. Analysis of reporter chimeric RNAs bearing the NF90 signature motif. (A) Schematic of plasmids used in reporter analyses: a control
plasmid expressing a chimeric RNA that contained the EGFP CR linked to the GAPDH 30UTR (pEGFP-GAPDH), a chimeric RNA in which the
NF90 ‘ideal’ motif (the top nt position at each site in Figure 2A) was inserted in the middle of the GAPDH 30UTR (pEGFP-NF90m) and a chimeric
RNA in which the speciﬁc NF90 motif hit in the DCK mRNA was inserted in the middle of the GAPDH 30UTR (pEGFP-DCKm). (B) HeLa cells
were transfected with plasmids pEGFP-GAPDH, pEGFP-NF90m and pEGFP-DCKm; 24h later cells were lysed and the association of the
expressed chimeric RNAs with NF90 was assessed by RNP IP, followed by RT-qPCR detection of EGFP PCR products. The data are represented
as enrichment of each transcript in NF90 IP relative to IgG IP samples. (C) Cells were transfected with control or NF90-directed siRNAs for 24h
and then with the plasmids described in panel (A); an additional 24h later, EGFP signals were assessed by western blot analysis and EGFP
intensities (as well as the intensities of loading control a-tubulin) were measured by densitometry. The relative changes in EGFP signal intensities,
normalized to diﬀerences in loading control signals, are indicated (fold). (D) In cells that were processed as in (C), the whole-cell abundance of
chimeric EGFP mRNAs was measured by RT-qPCR. (E) Following transfection as explained in panel (C), the nuclear and cytosolic fractions were
prepared and the abundance of each of the three EGFP chimeric reporters was tested by RT-qPCR analysis; data represent the average from two
experiments showing similar results. (F) Representative western blot analysis of NF90 and NF110 in cells transfected with either Ctrl siRNA or
NF90 siRNA. The data in (B) and (D) represent the means and S.E.M. from three independent experiments.
Nucleic AcidsResearch, 2010, Vol.38,No. 1 231Figure 4. Inﬂuence of the NF90 motif on reporter translation. (A) Nascent EGFP production was monitored following a brief (20-min-long)
incubation of HeLa cells with L-[
35S]methionine and L-[
35S]cysteine after transfection with either Ctrl siRNA or NF90 siRNA, and 24h later
with pEGFP-GAPDH, pEGFP-NF90m or pEGFP-DCKm; 24h after that, lysates were prepared and subjected to IP using either anti-EGFP or
anti-GAPDH antibodies. The incorporation of radiolabeled amino acids into the newly synthesized EGFP and GAPDH proteins was assessed by
electrophoresis through 12% SDS-containing polyacrylamide gels and by visualization and quantitation using a PhosphorImager. (B) Representative
polysome proﬁles prepared from cells that were transfected with Ctrl or NF90 siRNAs. The direction of sedimentation (arrow), as well as the
components of the translational machinery in each fraction [no ribosome components (–), ribosome subunits (Subunits), monosome (Mono.), LMWP
(low molecular weight polysomes) and HMWP (high molecular weight polysomes)] are indicated. (C) Representative distribution of the chimeric
EGFP reporter mRNAs (top graphs) as well as the housekeeping UBC mRNA (bottom graph) in Ctrl siRNA and NF90 siRNA populations. The
relative distribution of these mRNAs was tested by preparing cytoplasmic lysates from cells treated as in panel (A), fractionating them through
sucrose gradients and collecting 10 fractions for analysis. RNA was extracted from each fraction and the levels of EGFP and UBC mRNAs in each
fraction from each population were measured by RT-qPCR and plotted as a percentage of the total mRNA in the gradient. The data shown are
representative of three independent experiments.
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NF90 motif.
NF90 binding to endogenous target mRNAs
Next, we focused our attention on the binding of NF90 to
speciﬁc target mRNAs. First, using HeLa cells, we
validated the interaction of endogenous NF90 with
several of the endogenous transcripts identiﬁed by
microarray analysis (Figure 1). Following RNP IP, we
tested the individual enrichment of putative target
mRNAs by performing RT followed by qPCR using
sequence-speciﬁc primer pairs. This analysis showed that
all mRNAs were more abundant in NF90 IP samples than
in IgG IP samples (except EIF2A mRNA); binding of
NF90 to housekeeping transcripts that were not predicted
NF90 targets (UBC and SDHA mRNAs) was included to
monitor the non-speciﬁc binding of NF90 to general
cellular mRNAs (Figure 5A). Second, binding of NF90
to endogenous target mRNAs was further assayed by
preparing biotinylated transcripts (heavy bar) which
spanned sections of the 30UTR (Figure 5B, white
segments) that included NF90 motif hits. Following
incubation of the biotinylated RNAs with lysates
prepared from HeLa cells, the biotin RNA–protein
complexes were pulled down using streptavidin-coated
beads and the presence of NF90 in the complexes
was detected by western blot analysis. As shown in
Figure 5C, all of the biotinylated RNAs associated with
NF90, except the negative control, biotinylated UBC.
Interestingly, NF110 did not appear to bind the
biotinylated transcripts, as it was only detected in the
‘Input’ sample. These interactions appeared to be
speciﬁc, as probing the biotin pulldown samples with an
anti-HuR antibody showed that HuR only associated with
a subset of these AU-rich biotinylated sequences.
As observed with the chimeric reporter (Figure 3D),
NF90 silencing did not signiﬁcantly increase the steady-
state levels of the endogenous target mRNAs (Figure 6A),
nor did it aﬀect their half-lives, which were overall high for
the mRNAs studied regardless of NF90 abundance
(Figure 6B). Based on the presence of at least one hit of
the NF90 signature motif, numerous other mRNAs were
predicted to be NF90 targets (the complete list of putative
target transcripts is provided as Supplementary Table S2).
Testing of a subset of these mRNAs veriﬁed that these
mRNAs did associate with NF90 (Figure 7A), indicating
that the presence of the AU-rich signature motif
successfully predicted whether an mRNA was a target of
NF90. As seen with other targets, NF90 silencing did not
alter the mRNA steady-state levels (Figure 7B).
NF90 silencing promotes the translation
of NF90 target mRNAs
As NF90 did not inﬂuence the abundance of endogenous
target mRNAs, we examined its consequences on target
mRNA translation. First, we examined the association of
target mRNAs with polysome gradients. As shown in
Figure 8A, the CYCA and EIF4E mRNAs showed
proportionately higher levels in the polysomal fractions
when NF90 was silenced. Nascent translation analysis
showed that translation of the CDC2 and CYCA
mRNAs was higher in the NF90 siRNA group, as
35S-
Met/Cys incorporation into de novo translated Cdc2 and
cyclin A was elevated after silencing NF90 (Figure 8B).
Figure 5. RNA-binding assays (array-identiﬁed targets). (A) RNP IP
analysis of the association of NF90 with mRNAs identiﬁed by microarray
analysis, using HeLa cells. For the mRNAs shown, the enrichment of the
mRNAs in NF90 IP compared with IgG IP is indicated. Diﬀerences in
sample input were normalized by measuring UBC mRNA. Black bars,
array-identiﬁed NF90 target mRNAs; gray bars, non-NF90 target
mRNAs. Data are the means ±S.E.M. from three independent
experiments. (B) Schematic of the biotinylated transcripts prepared for
analysis. Gray, 50UTR; black, CR; white, 30UTR. (C) Equimolar
amounts of the biotinylated transcripts shown in (B) were incubated
with HeLa cell lysates. Following pulldown analysis using streptavidin-
coated beads, the presence of NF90 and HuR was tested by western blot
analysis. A control lysate aliquot was included (Input).
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antibody did not precipitate suﬃcient labeled EIF4E for
analysis. Although the increases in polysomal association
and nascent translation were relatively modest, NF90 had
a marked inﬂuence on the steady-state abundance of the
encoded proteins. For those tested, NF90 silencing
increased their abundance between 2.5- and 5.0-fold
(Figure 8C), in keeping with the notion that NF90
functioned as a translational repressor for these target
mRNAs. Finally, as several cyclins were higher in NF90-
silenced cells, we compared the rate of DNA replication in
Ctrl and NF90 siRNA groups. As shown in Figure 8D,
NF90 increased DNA biosynthesis moderately in HeLa
cells.
DISCUSSION
We report the en masse identiﬁcation of NF90 target
mRNAs. Among the 30UTRs of these mRNAs, we
found a shared 25- to 30-nt-long, AU-rich RNA signature
motif (Figure 2). Heterologous reporter constructs bearing
this motif revealed that NF90 did not change the stability
of mRNAs carrying this sequence nor did it change the
subcellular concentration of the mRNAs; instead, NF90
prevented the translation of target mRNAs, as determined
by studying nascent translation and mRNA distribution
on polysome gradients (Figures 3 and 4). The presence
of the NF90 signature motif successfully identiﬁed
endogenous NF90 target transcripts; testing of several
endogenous targets further supported a translation
inhibitory function for NF90 (Figure 7). In keeping with
the proliferative inﬂuence of proteins encoded by
several NF90 target mRNAs, silencing NF90 moderately
enhanced DNA replication (Figure 8).
The discovery that NF90 did not selectively block the
transport of target mRNAs (Figure 3E) was unexpected,
given earlier ﬁndings by Pfeifer and colleagues (36) that
NF90 retained mRNAs in the nucleus. However, the
Pfeifer study showed that silencing NF90 broadly
increased the export of poly(A) and elevated global
Figure 6. Steady-state levels and stability of array-identiﬁed NF90 targets. (A) The steady-state levels of NF90-associated mRNAs identiﬁed by
microarray analysis was measured by RT-qPCR analysis in HeLa cells expressing normal (Ctrl siRNA) or reduced (NF90 siRNA) NF90 levels. (B)
The stability of several NF90 target mRNAs was assessed by incubating HeLa cells (transfected as in panel A) with actinomycin D (2mg/ml),
collecting total RNA at the times shown, measuring the abundance of each mRNA by RT-qPCR, and normalizing it to the abundance of 18S rRNA
(also measured by RT-qPCR). UBC mRNA was included as a housekeeping control transcript. Data are the means ±S.E.M. from three independent
experiments.
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increase in translation in NF90 silenced cells, nor do they
suggest that target mRNAs bearing the signature motif
were selectively retained in the nucleus. The discrepancy
between our results and those of Pfeifer et al. could be due
to diﬀerences in the degree of silencing in both studies, the
selective targeting of NF90 in our work and NF90/NF110
in the Pfeifer report, and the times examined after NF90
silencing which were shorter in our study (48h) than in
that of Pfeifer and coworkers (72h and 96h). Since NF90
repressed the translation of target mRNAs bearing the
NF90 motif, but did not appear to aﬀect their cytosolic
abundance, our data suggest that NF90 associates with
this subset of target mRNAs after they have reached the
cytoplasm. Whether or not the mRNA subset is exported
to the cytoplasm by a shared export factor or uses the
general mRNA export machinery remains to be studied.
Another question that remains unanswered is the
mechanism whereby NF90 represses translation. The
fact that the polysomes are smaller suggests that
translational initiation is reduced. To explain this eﬀect,
it could be hypothesized that binding of NF90 to a target
mRNA could block the assembly of components of the
translation initiation apparatus on that speciﬁc mRNA.
Alternatively, NF90 could recruit one or several types of
microRNAs onto the target mRNA, thereby repressing
translation through the action of RISC (RNA-induced
silencing complex), as recently shown for another RBP
(42). Yet another mechanism of target mRNA silencing
could be linked to the ability of RBPs that bind to
double-stranded RNAs (DRBPs) to associate amongst
themselves, possibly by forming dsRNA bridges. Thus, it
is possible that NF90 recruits onto target mRNAs other
DRBPs implicated in gene silencing, such as DICER,
PACT and TRBP, which are integral components of the
microRNA and RNAi machineries (43,44). It will be
interesting to investigate if recombinant puriﬁed NF90
binds to the consensus AU-rich signature motif;
however, in light of the above-mentioned evidence, the
speciﬁcity of NF90 is plausibly inﬂuenced by proteins
that associate with NF90 itself (43,44) or factors (RBPs,
microRNAs) that interact directly with the target
mRNAs. Therefore, the initial analysis reported here has
focused on NF90-mRNA interactions as identiﬁed within
the cytoplasmic milieu.
Although we previously identiﬁed MKP-1 mRNA as a
target of NF90, MKP-1 mRNA unexpectedly lacks
any predicted hits of the AU-rich NF90 motif described
here. Following treatment with H2O2, NF90 abundance
increased in the cytoplasm, its binding to MKP-1
mRNA was enhanced and it repressed translation of
MKP-1 mRNA but stabilized it (28). It is possible that
the subset of target mRNAs whose stability increases by
NF90 share a diﬀerent signature motif. It is also possible
that stress treatments (oxidative or otherwise) change the
aﬃnity of NF90 for a target RNA sequence. Perhaps
phosphorylation of NF90 by kinases [including known
kinases such as PKR (25)] may aﬀect its aﬃnity for
target transcripts, as shown for HuR (45). Accordingly,
it will be interesting to identify a signature motif in NF90
target mRNAs after exposure to a stimulus that alters the
subset of NF90-bound mRNAs. For TIAR, a C-rich
signature motif was found in target mRNAs under
unstimulated conditions; after exposure to ultraviolet
light, the signature motif was instead highly AU-rich
(41). The signature motif for TIA-1 was also AU-rich
(13). Thus, it is possible that under conditions of stress,
TIAR or TIA-1, both translational repressors, competes
with NF90 for binding to shared target mRNAs.
Although such a possibility remains to be tested
systematically, at least one example supports this mode
of action. NF90 binds with strong preference at a distal,
 250-base long segment of the MKP-1 30UTR, while TIA-
1 binds with moderate strength throughout the MKP-1
30UTR (28). In this instance, the association of NF90 to
MKP-1 mRNA increased after treatment with H2O2,
while binding of TIA-1 to MKP-1 mRNA decreased,
suggesting that for MKP-1 mRNA, NF90 and TIA-1
may bind competitively.
HuR can also function as a translational repressor,
although its signature motif is mainly U-rich (40). A
systematic comparison, validation and analysis of
competition and/or cooperation between HuR and
Figure 7. RNA-binding assays (predicted targets). (A) RNP IP analysis
of the association of NF90 with mRNAs predicted to be NF90 targets
based on the presence of one or several NF90 hits in their 30UTRs. The
enrichment of the mRNAs in NF90 IP compared with IgG IP is
indicated. Diﬀerences in sample input were normalized using by
measuring UBC mRNA. (B) The steady-state levels of putative NF90
target mRNAs were measured by RT-qPCR analysis in HeLa cells
expressing normal (Ctrl siRNA) or reduced (NF90 siRNA) NF90
levels. Data in (A) and (B) are the means±S.E.M. from three
independent experiments.
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of this study. However, HuR was also shown to interact
with the MKP-1 mRNA in a modestly cooperative fashion
with NF90, since silencing NF90 slightly lowered the
interaction of HuR with MKP-1 mRNA and vice versa
(28). Like TIA-1, HuR did not bind exactly to the same
MKP-1 30UTR segment as NF90 did (28); this ﬁnding led
us to postulate that HuR and NF90 may bind
cooperatively by interacting with the MKP-1 30UTR at
the same time. As HuR, TIAR and TIA-1 likely do not
bind to the very same location on the shared mRNAs, the
relative distance, sequence and dynamics of association
between NF90 and these RBPs likely vary among the
mRNAs. Therefore, the functional consequences of their
association are probably determined by each speciﬁc
mRNA and need to be analyzed on a case-by-case basis.
In conclusion, this study provides a ﬁrst systematic
analysis of NF90-RNA interactions. Given NF90’s
ability to bind DNA and RNA and its inﬂuence on
mRNA transport, stability and translation, testing its
functions individually appears to be most informative.
The AU-rich signature element described in this report
identiﬁes a particular subset of NF90 target mRNAs
subject to translational repression by NF90. Many other
RBPs, such as TTP, AUF1, BRF1, KSRP and HuR, also
have broad aﬃnity for AU-rich RNA. Therefore,
complexes containing NF90 and a target mRNA bearing
this motif are likely subject to rich post-transcriptional
processes involving other RBPs, which may compete or
cooperate with NF90 in determining the post-
transcriptional fate of the target transcripts. Further
knowledge of the post-translational modiﬁcation of
Figure 8. Inﬂuence of NF90 on target mRNAs. (A) The relative association of cyclin A and EIF4E mRNAs in cells with normal or reduced NF90
was studied as described in Figure 4. (B) Analysis of nascent translation for Cdc2 and Protein A; new protein synthesis was studied as described in
the legend of Figure 4, using anti-cyclin A, anti-Cdc2 and control IgG antibodies. Percent changes in nascent cyclin A and Cdc2 protein levels are
indicated. (C) HeLa cells were transfected with Ctrl or NF90 siRNAs; 48h later, the levels of the proteins shown were assessed by western blot
analysis. Signal intensities were quantiﬁed by densitometry and represented (fold). (D) By 48h after transfection with either Ctrl siRNA or NF90
siRNA, the proliferation of HeLa cells was studied by measuring
3H-thymidine incorporation; data are the means ±S.E.M. from three independent
experiments.
236 Nucleic Acids Research, 2010, Vol. 38,No. 1NF90 and its inﬂuence on the metabolism of target
mRNAs will give critical insight into the function of this
pivotal regulator of gene expression.
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